Today: 17 July 2026
Oracle (NYSE:ORCL) shares fall as $20 billion AI strategy intensifies dilution concerns
17 July 2026
2 mins read

Oracle (NYSE:ORCL) shares fall as $20 billion AI strategy intensifies dilution concerns

NEW YORK, July 17, 2026, 08:09 (EDT) — Shares in Oracle dropped, heightening market fears that the company’s $20 billion AI initiative could lead to increased dilution.

Oracle slipped 2.0% in premarket trading on Friday, adding to Thursday’s 6.25% decline. The latest fall increased concerns about possible dilution from its proposed $20 billion share sale.

Oracle closed at $124.21 on Thursday, after hitting a new 52-week low of $123.66. Falling share prices require Oracle to issue additional shares to raise the same amount of cash.

An initial estimate, based on a sale at Thursday’s closing price, indicates 161 million shares would need to be issued under the full authorization—representing 5.6% of Oracle’s June share count. Current shareholders’ stakes would decline by around 5.3%.

Initial estimates are based on 2.880 billion shares outstanding as of June 12. Figures do not include fees or market impact.

Oracle price benchmarkShares required for $20 billionIncrease in total shares
$345.72 — September 10 high57.9 million2.0%
$201.26 — June 10 close99.4 million3.4%
$124.21 — July 16 close161.0 million5.6%

At the peak last September, raising the same amount required approximately 58 million shares. The latest estimate is almost three times that figure.

The final amount raised could vary. Oracle may offer stock incrementally and is not required to sell the entire sum. Factors such as fees, timing, and the effect on price remain relevant.

Oracle projects approximately $40 billion in debt and equity financing for fiscal 2027, which encompasses the $20 billion at-the-market program. The company does not anticipate any additional debt issuance throughout calendar 2026.

Flexibility in debt has decreased. S&P Global Ratings downgraded Oracle to BBB- on July 9, positioning it just one level above speculative grade.

S&P calculates that OpenAI accounts for nearly 50% of Oracle’s $638 billion in outstanding commitments. This level of concentration increases the importance of funding conditions.

Demand signals are robust. The backlog increased by 363%, with fiscal 2026 cloud-infrastructure revenue up 77%. Oracle projects first-quarter cloud revenue growth between 58% and 64% in dollar terms.

Cash conversion proved more challenging. Operating cash flow totaled $32.0 billion in fiscal 2026, while free cash flow recorded a negative $23.7 billion.

Oracle reported that customers have prepaid or provided $75 billion worth of AI hardware. Executives noted this lowers the capital requirement for data centers.

Bigger market declines were recorded as well. Nasdaq 100 futures dropped 1.55% at 07:07 EDT. “This is morphing from just a chip sell-off into something far broader,” said Chris Beauchamp, chief market analyst at IG Group . Reuters

Oracle’s trading volume on Thursday was 76% higher than its 65-day average. The stock fell 11.7% over the week through Thursday, following a week in which it was largely unchanged.

Investors are set to monitor if Oracle issues shares near current lows next week. Such a move would indicate if backlog growth might counteract dilution.

Risks: The projection is based on a single sale price and complete program participation. Actual results for timing, proceeds and dilution may vary. Delays in AI projects or heavy reliance on a few customers may lower the cash value of the backlog.

Iwona Majkowska is a financial markets journalist at TS2.tech, specializing in stocks, artificial intelligence and technology. A graduate of the Warsaw School of Economics, she previously worked in equity research and financial analysis before focusing on market reporting. Her daily coverage helps investors follow major developments across U.S. and global markets. Follow Iwona Majkowska on Google News.

Stock Market Today

  • CFPs Double as Death Doulas to Guide Clients Through End-of-Life Financial Choices
    July 17, 2026, 10:36 AM EDT. An unexpected terminal illness can abruptly alter your financial planning. Some Certified Financial Planners (CFPs) are also death doulas, combining their financial knowledge with end-of-life care. Their dual expertise assists clients with urgent money matters during times of emotional strain, making sure plans are revised realistically and compassionately. This approach blends financial advice with end-of-life support, helping manage assets, healthcare costs and legacy issues when they matter most, and allowing people to maintain control of their financial futures in challenging situations.
IREN Limited (NASDAQ:IREN) security hire sharpens focus on a 23-fold AI revenue test (GlobeNewswire)
Previous Story

IREN (NASDAQ:IREN) shares fall, highlighting attention on 33-fold increase in AI revenue

Wall Street Boosts Ratings But Leaves Price Targets Unchanged as Uranium Momentum Slows
Next Story

Wall Street Boosts Ratings But Leaves Price Targets Unchanged as Uranium Momentum Slows

Go toTop